Reports

Independent editorial reports from CDMO Signal. Quarterly snapshots of the biopharma CDMO landscape — rankings, FDA activity, GMP density leaders, and what sponsors should watch. All reports are free, cite primary regulatory sources, and are permanent URLs so citations don't rot.

Q3 2026 · Published 2026-07-18
State of CDMO Quality — Q3 2026
The independent snapshot: rankings, FDA activity, GMP density, and what sponsors should watch.